If you quit making foolish remarks about how we should be worried, grow a pair and buy, or just shut your pie hole and wait, then no one will pick on you. Most here are not the day traders that never intended to make a long term investment and got stuck. Most here know that the long term growth will show that anything under .20 and definitely under .10 was a great buy. If you cant justify buying here you're a day trader looking to invest peanuts and need a .00** entry point like another pussy that used to brag about the procedes of his great 360 dollar investment. Big deal! He knew he was a gutless wonder and could have made a pile if only he had a set. Your points were made more than once already, folks here made it clear that they feel those points are worthless to most of us, and you continue to repeat them. Are you stupid or do you always like to be the asshole at the party? Are you looking for help from us to determine the bottom? If so, why would you say we should be worried when you believe it will bounce back up? These contradictory bits of info are exactly what exposes you as a basher. We don't need to worry, we need to buy even if it does drop more. Especially since not one of us, you included, has an exact date for when the PR(s) that send this stock shooting will hit the board. As a result, even IF you actually do intend to buy the stock, your wait could be all in vane as it quadruples or better before you can pick up a single share. Only way it makes sense is if you're borrowing the money to invest with and the interest rate is ridiculously high. Naw, I'd say your one of our old hemorrhoids back to irritate us. Same style.
If you quit making foolish remarks about how we should be
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Gnosis Lab's Grand Re-Opening: A New Era for Diagnostics
Gnosis Lab Grand Re-Opening Celebration Gnosis, a modern diagnostic laboratory previously known as Mountain View Medical Laboratory, is excited to announce its grand re-opening at its flagship location. This event signifies a crucial transition for the lab as it seeks to blend years of reliable community service with a fresh identity and enhanced capabilities. Commitment...
Continue Reading
New Propane Contract Boosts Titan NRG (TTNN) Growth
Titan NRG, Inc. Announces Major Propane Contract Secured Titan NRG, Inc. (OTC: TTNN) has a big contract for the 150,000 gallons of propane supply. Given to one of its subsidiaries, this contract represents a significant turning point for the business. Under this contract, propane will be delivered over the next year to a southern Arizona reservation. Crucially in securing...
Continue Reading
Bitcoin Price Decline: Impact of DOJ and Economic Conditions
Bitcoin Price Experiences a Notable Decline Bitcoin has recently faced a serious downturn, falling to around $93,925 as fears surrounding U.S. interest rate changes and potential government sales of Bitcoin emerged. This has created a concerning environment for cryptocurrency investors, highlighting the volatility of digital assets. Market Sentiment and Economic Shifts...
Continue Reading
Cogitate and One Inc Team Up to Revolutionize Payments
Cogitate Partners with One Inc to Transform Digital Payments -Customers Enjoy a Seamless Experience by Unifying All Payment Flows into One Comprehensive Platform- Cogitate, a provider of cloud-native core policy, billing, and claims applications for insurers, is excited to announce its partnership with One Inc, the leading digital payments network specifically for the...
Continue Reading
Alnylam Pharmaceuticals Achieves New Stock Milestone of $287.88
Alnylam Pharmaceuticals Reaches Record Stock Price Alnylam Pharmaceuticals Inc. has recently made headlines after its stock price reached a remarkable all-time high of $287.88. This surge demonstrates a substantial increase in investor confidence, bolstered by an impressive 1-year change of 71.84% in the company's stock. Known for its groundbreaking work in RNA...
Continue Reading